Spyre Therapeutics
SYRE
#4131
Rank
ยฃ2.01 B
Marketcap
ยฃ26.00
Share price
3.53%
Change (1 day)
23.62%
Change (1 year)

Revenue for Spyre Therapeutics (SYRE)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of ยฃ0.69 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Spyre Therapeutics from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A-100%
2023 ยฃ0.69 M-63.87%
2022 ยฃ1.92 M-86.13%
2021 ยฃ13.88 M
2020 N/A
2019 N/A-100%
2018 ยฃ3.06 M-20.45%
2017 ยฃ3.85 M2.66%
2016 ยฃ3.75 M-8.66%
2015 ยฃ4.1 M
2014 N/A